Compare BioNano Genomics Inc (BNGO) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs ProShares Ultra Semiconductors — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while ProShares Ultra Semiconductors trades at $91.85. The key difference: ProShares Ultra Semiconductors is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | USD | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $4.92 | $113.53 |
52-Week Low | $1.06 | $40.97 |
Enterprise Value | $16.26M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
